8A0E image
Entry Detail
PDB ID:
8A0E
EMDB ID:
Keywords:
Title:
CryoEM structure of DHS-eIF5A1 complex
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2022-05-27
Release Date:
2023-04-05
Method Details:
Experimental Method:
Resolution:
2.80 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Deoxyhypusine synthase
Mutations:K329A
Chain IDs:A, B
Chain Length:371
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Deoxyhypusine synthase
Chain IDs:C, D
Chain Length:371
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Eukaryotic translation initiation factor 5A
Chain IDs:E
Chain Length:156
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CSS C CYS modified residue
Primary Citation
Cryo-EM structure of human eIF5A-DHS complex reveals the molecular basis of hypusination-associated neurodegenerative disorders.
Nat Commun 14 1698 1698 (2023)
PMID: 36973244 DOI: 10.1038/s41467-023-37305-2

Abstact

Hypusination is a unique post-translational modification of the eukaryotic translation factor 5A (eIF5A) that is essential for overcoming ribosome stalling at polyproline sequence stretches. The initial step of hypusination, the formation of deoxyhypusine, is catalyzed by deoxyhypusine synthase (DHS), however, the molecular details of the DHS-mediated reaction remained elusive. Recently, patient-derived variants of DHS and eIF5A have been linked to rare neurodevelopmental disorders. Here, we present the cryo-EM structure of the human eIF5A-DHS complex at 2.8 Å resolution and a crystal structure of DHS trapped in the key reaction transition state. Furthermore, we show that disease-associated DHS variants influence the complex formation and hypusination efficiency. Hence, our work dissects the molecular details of the deoxyhypusine synthesis reaction and reveals how clinically-relevant mutations affect this crucial cellular process.

Legend

Protein

Chemical

Disease

Primary Citation of related structures